Julius Danesh, MD
Pain Medicine · Martins Ferry, OHNPI 1740683119
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medtronic at 57.6% of the total. Reporting peaked in 2023 at $1,657 and has fallen 82.2% since, to $295 in 2025.
Across 40 payments — averaging $64.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Stryker$420
- SPR Therapeutics, Inc$207
- Nevro Corp.$179
- Abbott$142
- Tonix Medicines, Inc.$77
- plus $66 from 2 others
What the payments were for
- Travel & lodging$83132%
- Food & beverage$1,48958%
- Education$25510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 26 | $1,484 |
| Stryker | 4 | $420 |
| SPR Therapeutics, Inc | 2 | $207 |
| Nevro Corp. | 4 | $179 |
| Abbott | 1 | $142 |
| Tonix Medicines, Inc. | 1 | $77 |
| Si-bone, Inc. | 1 | $49 |
| Avanos Medical | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$840
- SPINEJACK$310
- Proclaim IPG$142
- SPRINT PNS System$139
- RESTORE$112
How this compares
$2,575 in reported general payments places this provider in the 55th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 14 | $9,729 |
| Xtampza ErOxycodone Myristate | 12 | $7,704 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 216 | $3,924 |
| Pregabalin | 223 | $3,215 |
| Gabapentin | 285 | $3,136 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 156 | $3,101 |
| Tramadol Hcl | 218 | $1,125 |
| Lidocaine | 11 | $904 |
| Baclofen | 94 | $737 |
| Duloxetine Hcl | 75 | $731 |
| Oxycodone Hcl | 43 | $524 |
| Celecoxib | 33 | $523 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $407 |
| Tizanidine Hcl | 51 | $350 |
| Nortriptyline Hcl | 21 | $180 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Martins Ferry
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.